tiprankstipranks
Trending News
More News >
Knight Therapeutics (TSE:GUD)
TSX:GUD
Canadian Market
Advertisement

Knight Therapeutics (GUD) Technical Analysis

Compare
102 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
1Bullish
6Neutral
15Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Knight Therapeutics’s (GUD) Moving Averages Convergence Divergence (MACD) indicator is -0.10, suggesting Knight Therapeutics is a Sell.
Knight Therapeutics’s (GUD) 20-Day exponential moving average is 5.90, while Knight Therapeutics’s (GUD) share price is C$5.8, making it a Sell.
Knight Therapeutics’s (GUD) 50-Day exponential moving average is 6.04, while Knight Therapeutics’s (GUD) share price is C$5.8, making it a Sell.

Knight Therapeutics (GUD) Pivot Points

Oct 23, 2025, 10:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.80
5.81
5.84
5.85
5.88
5.89
5.92
Fibonacci
5.81
5.83
5.84
5.85
5.87
5.88
5.89
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Knight Therapeutics (GUD) Moving Averages

Oct 23, 2025, 10:31 AM
Period
Simple
Exponential
MA5
5.82Sell
5.82Sell
MA10
5.81Sell
5.83Sell
MA20
5.87Sell
5.90Sell
MA50
6.17Sell
6.04Sell
MA100
6.10Sell
6.04Sell
MA200
5.93Sell
5.89Sell
Knight Therapeutics’s (GUD) 10-Day exponential moving average is 5.83, while Knight Therapeutics’s (GUD) share price is C$5.8, making it a Sell.
Knight Therapeutics’s (GUD) 100-Day exponential moving average is 6.04, while Knight Therapeutics’s (GUD) share price is C$5.8, making it a Sell.
Knight Therapeutics’s (GUD) stock price is C$5.8 and Knight Therapeutics’s (GUD) 50-day simple moving average is 6.17, creating a Sell signal.
Knight Therapeutics’s (GUD) stock price is C$5.8 and Knight Therapeutics’s (GUD) 100-day simple moving average is 6.10, creating a Sell signal.
Knight Therapeutics’s (GUD) stock price is C$5.8 and Knight Therapeutics’s (GUD) 200-day simple moving average is 5.93, creating a Sell signal.

Knight Therapeutics (GUD) Technical Indicators

Oct 23, 2025, 10:31 AM
Name
Value
Implied Action
RSI (14)
37.57
Neutral
STOCH (9,6)
66.67
Neutral
STOCHRSI (14)
53.26
Neutral
MACD (12,26)
-0.10
Sell
ADX (14)
38.75
Neutral
Williams %R
-57.14
Buy
CCI (14)
-49.90
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
55.89
Neutral
ROC
-2.19
Sell
Knight Therapeutics’s (GUD) Relative Strength Index (RSI) is 37.57, creating a Neutral signal.
Knight Therapeutics’s (GUD) Trend Strength Indicator (ADX) is 38.75, creating a Neutral signal.
Knight Therapeutics’s (GUD) Commodity Channel Index (CCI) is -49.90, creating a Neutral signal.
Knight Therapeutics’s (GUD) Price Rate of Change (ROC) is -2.19, creating a Sell signal.

FAQ

Is GUD a Buy, Hold, or Sell?
Based on GUD’s technical indicators, GUD is a Strong Sell.
    What is GUD’s RSI (14)?
    GUD’s RSI (14) is 37.57, which suggests GUD is a Neutral.
      What is GUD’s MACD?
      GUD’s MACD is -0.10, which suggests GUD is a Sell.
        What is GUD’s 5-day moving average?
        GUD’s 5-day moving average is 5.82, which suggests GUD is a Sell.
          What is GUD’s 20-day moving average?
          GUD 20-day moving average is 5.87, which suggests GUD is a Sell.
            What is GUD’s 50-day moving average?
            GUD’s 50-day moving average is 6.17, which suggests GUD is a Sell.
              What is GUD’s 200-day moving average?
              GUD’s 200-day moving average is 5.93, which suggests GUD is a Sell.
                What is GUD’s Williams % R (14)?
                GUD’s Williams % R (14) is -57.14, which suggests GUD is a Buy.
                  What is GUD’s CCI (14)?
                  GUD’s CCI (14) is -49.90, which suggests GUD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis